The Value of Vision: The case for investing in eye health
The solutions to sight loss already exist—simple, proven, and affordable. By scaling these accelerators in low- and middle-income countries, we can boost not just eye health, but overall health, learning, employment, and productivity—and achieve one of the best returns in global health.
Country investment case
Investing $7 billion USD in eye health in LMICs over 2026-2030 will deliver $199 billion USD in economic benefits,
a 1:28 return on investment – one of the best in global health. Plus:
The benefits of investment
Good vision is foundational to economic and societal participation. Investment in eye care will lead to higher employment, improved productivity, better educational outcomes, reduced traffic accidents, and improved mental health and longevity.
Total economic benefit by 2030
Total other benefits by 2030
Sight loss averted by 2030
The investment could curb global sight loss by 24%, preventing 255 million cases by 2030.
Currently selected
Increased employment
Individuals with MSVI or blindness are approximately 30%[1] less likely to secure employment compared to those with unimpaired vision. Sight loss limits individuals’ ability to access and retain employment and contributes to substantial society-wide economic productivity losses.
However, evidence indicates that investment in straightforward eye health interventions can swiftly and sustainably reverse these effects. Our analysis suggests that, following the recommended investments, approximately 2.1 million more people could gain employment, resulting in $37 billion additional income over the period of 2026-2030, increasing from $1.1 billion in 2026 to $15 billion by 2030.
Currently selected
Enhanced occupational productivity
Individuals working with uncorrected vision impairment experience reduced productivity compared to their colleagues with good vision. This is caused by barriers to performing visual tasks and reduced access to information, as well as physical discomfort, isolation, and mental health challenges that further impact effectiveness.
Evidence across diverse contexts shows that correcting near vision impairment can significantly boost productivity or income – by anywhere from 6% up to 67%,[2][3][4][5][6][7] often with nearly immediate effects.
Adopting a conservative estimate of 10%, we expect this intervention to generate income gains totaling $115 billion during 2026-2030, starting from $7.5 billion in 2026 to $43 billion by 2030.
Currently selected
Reduced caregiving burden
Caregivers of individuals with vision impairment face substantial demands that affect both their productivity and quality of life. Many of these caregivers – the majority of whom are women – would otherwise be active in the workforce. However, balancing caregiving duties with employment can lead to reduced working hours, unexpected absences, or even withdrawal from the workforce.
By restoring vision, this burden can be eased by freeing caregiver time for employment and other productive activities. Employing conservative impact assumptions, we estimate that improved vision could unlock a total of $20 billion additional productivity, starting from $726 million in 2026 to $7.7 billion by 2030.
Currently selected
Improved learning for children
Caregivers of individuals with vision impairment face substantial demands that affect both their productivity and quality of life. Many of these caregivers – the majority of whom are women – would otherwise be active in the workforce. However, balancing caregiving duties with employment can lead to reduced working hours, unexpected absences, or even withdrawal from the workforce.
By restoring vision, this burden can be eased by freeing caregiver time for employment and other productive activities. Employing conservative impact assumptions, we estimate that improved vision could unlock a total of $20 billion additional productivity, starting from $726 million in 2026 to $7.7 billion by 2030.
Currently selected
Fewer road crashes
When people can’t see, they can’t drive safely. That’s why in most countries, good vision is necessary to receive a driver’s license. But in LMICs, driving license systems are often poorly enforced or widely informal.
Poor vision increases the risk of road traffic accidents by nearly 50%.[8] Traffic-related mortality is the leading cause of death among individuals aged 5–29[9] in LMICs with profound consequences for individuals and their families.
Our analysis suggests vision correction could reduce this burden saving an extra 5,847 lives and preventing more than 211,000 traffic injuries over 2026-2030.
Currently selected
Improved mental health
Sight loss is closely linked to mental health. There is consistent evidence that losing sight or living with eye disease significantly increases the risk of depression. Approximately 25%[10] of individuals with vision impairment experience depression or depressive symptoms, and similarly caregivers can also be affected by depression.
Evidence consistently shows that restoring vision significantly improves an individual’s mental health. About one in five of these cases associated with vision impairment can be alleviated through vision correction. By 2030, we estimate the avoidance of 1.7 million cases of depression.
Currently selected
Increased longevity
Vision impairment not only affects the eye, but exacerbates health, longevity and quality of life challenges as people age.
Vision impairment is also associated with a heightened risk of mortality, particularly among older adults. The risk is nearly doubled [11] in individuals with MSVI, and is compounded by comorbidities, cognitive decline and an increased risk of falls and injuries.
Focusing on the 65–75 age group, our analysis indicates that improved visual health could prevent approximately 12,300 deaths and yield nearly 80,000 additional years of life within the next five years.
Currently selected
Accelerators in eye care needed
This investment case outlines a clear path to reduce the significant but addressable burden of visual impairment. It recommends six practical accelerator interventions – two for all settings and four tailored to middle-income countries. These are designed for rapid impact within one to three years at low cost, while also strengthening the eye health workforce and building sustainable systems for the long term.
Total investment required
Delivering the benefits outlined in this investment case will require an additional $7.1 billion over the next five years – beginning at $508 million in 2026 and scaling up to $2.2 billion by 2030.
Currently selected
Beyond 2030
If we reached the 1 billion people living with avoidable sight loss, every year there would be even more economies boosted and lives transformed.
What leaders need to do
Here are the key actions for leaders worldwide to translate this investment case into reality.
Act
- Leadership and commitment from the highest levels of Government.
- Activate nationally owned plans to deliver change and an integrated approach.
- Implement policy changes to address vision, recognising it as a whole-of-life issue that needs a holistic, whole-of -government approach.
Allocate
- Increase resources, recognising the return of investment that is possible both nationally and internationally.
- Explore innovative funding mechanisms and new ways to fund eye health.
- Foster partnerships with the private sector.
Accelerate
- Collaborate across the public and private sector and wider society to harness the educational and societal benefits of addressing poor vision.
- Implement the 6 accelerator interventions quickly and as a minimum and scale these up as progress is made.
- Harness technology and fast-track research and development in this area.
References
Authors
Led by
Brad Wong
Jack Hennessy
Jude Stern
Core writing group
(by surname alphabetical order)
Gladys Atto
Moroto Regional Referral Hospital
Sarah Beeching
Oshun Partnership
Anthea M. Burnett
IAPB; The University of New South Wales
Matthew J. Burton
International Centre for Eye Health, London School of Hygiene & Tropical Medicine
Megan E. Collins
Wilmer Eye Institute, Johns Hopkins School of Medicine
Nathan Congdon
Queen’s University Belfast, Orbis International, Zhongshan Ophthalmic Center (Sun Yat-sen University)
Maggie Dawson
EYElliance
Bryce Everett
Mettalytics
KD Frick
Johns Hopkins Carey Business School
Wenyi Hu
IAPB
Iain Jones
Sightsavers
Ana Patricia Marques
International Centre for Eye Health, London School of Hygiene & Tropical Medicine
Michael Morton
IAPB
Raja Narayanan
Flaum Eye Institute, University of Rochester
Mark Radin
IAPB
Mai Vu
The Fred Hollows Foundation
Sabrina von Wegerer Elizeche
Fundación Visión (Paraguay)
Mayinuer Yusufu
IAPB